Response to "Letter to the Editor for 'Hypertonic Saline Versus Other Intracranial-Pressure-Lowering Agents for Patients with Acute Traumatic Brain Injury: A Systematic Review and Meta-analysis'"

Neurocrit Care. 2024 Feb;40(1):377-378. doi: 10.1007/s12028-023-01876-1. Epub 2023 Nov 13.

Authors

Keeley Bernhardt¹, William McClune¹, Matthew J Rowland^{2

3}, Akshay Shah⁴

Affiliations

¹ University of Oxford Medical School, Oxford, UK.
² Wellcome Wolfson Institute for Experimental Medicine, Queen's University, Belfast, UK.
³ Cardiovascular, Renal, and Metabolism Group, Novartis, London, UK.
⁴ Nuffield Department of Clinical Neurosciences, Level 6 West Wing, John Radcliffe Hospital, University of Oxford, Oxford, UK. akshay.shah@linacre.ox.ac.uk.

PMID: 37957417
DOI: 10.1007/s12028-023-01876-1

No abstract available

Publication types

Meta-Analysis
Systematic Review
Letter

MeSH terms

Brain Injuries*
Brain Injuries, Traumatic* / complications
Brain Injuries, Traumatic* / drug therapy
Humans
Saline Solution, Hypertonic

Substances

Saline Solution, Hypertonic